IMPROVING PATIENT CARE WITH
AI-DRIVEN TECHNOLOGY
We develop AI software that gives radiologists information
they do not have access to today.
FIRST FDA-CLEARED DIAGNOSTIC AI
Our decision support tool, QuantX™, helps radiologists significantly improve the diagnosis of breast abnormalities by extracting and analyzing data from MR images.
“QuantX™ gives me and our team an additional level of confidence that our conclusions are accurate. Efficient workflows are very important to us as we expand our breast care service line, and QuantX™ has streamlined our day-to-day, letting us focus on providing quality patient care.”
ADVANCED BREAST MRI ANALYSIS
DATA-DRIVEN
DECISION MAKING
SINGLE-CLICK LESION SEGMENTATION
IMAGE ANALYTICS +
BIOPSY PLANNING
RESEARCH PUBLISHED IN RADIOLOGY SHOWS IMPROVEMENT IN READER PERFORMANCE
In the De Novo clinical trial required for FDA clearance, 100% of the readers saw an improvement in accuracy when using QuantX™ for breast MRI interpretation compared to traditional CAD software.
TRANSFORM YOUR PRACTICE
AND PATIENT CARE
Indication: QuantX™ is indicated for the assessment and characterization of breast abnormalities from MRI data in patients presenting for high-risk screening, diagnostic imaging workup, or evaluation of extent of known disease. QuantX™ is not intended for primary interpretation of digital mammography images.
Risk Information: QuantX™ is not intended for primary interpretation of digital mammography images. Labeling also provides information to users about potential limitations of the device related to specific subpopulations. For use by licensed healthcare professionals only.